세계의 POC(Point of Care) 감염증 검사 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Point of Care Infectious Disease Testing Market size is anticipated to grow from USD 17.55 Billion in 2024 to USD 27.15 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97% during the forecast period of 2026 to 2033.

The global point of care (POC) infectious disease testing market is poised for significant growth, driven by the increasing demand for rapid and accurate diagnostic solutions in the face of rising infectious diseases. The COVID-19 pandemic has underscored the critical need for timely testing to control outbreaks and manage public health effectively. POC testing offers the advantage of delivering results within minutes, enabling healthcare providers to make informed decisions quickly and initiate appropriate treatment. As the focus on early detection and prevention of infectious diseases intensifies, the adoption of POC testing solutions is expected to accelerate, fostering innovation and investment in this vital market.

Moreover, advancements in technology are set to transform the POC infectious disease testing landscape. The integration of molecular diagnostics, microfluidics, and biosensors is enhancing the sensitivity and specificity of tests, allowing for the detection of a wide range of pathogens, including bacteria, viruses, and parasites. Additionally, the development of user-friendly devices that can be operated in various settings, from clinics to remote locations, is expanding access to testing. As healthcare systems increasingly prioritize decentralized testing approaches, the demand for innovative POC solutions that can deliver accurate results in real-time will continue to rise.

In addition, the growing emphasis on personalized medicine and the increasing focus on global health initiatives are expected to shape the future of the POC infectious disease testing market . As healthcare providers seek to tailor treatments to individual patient needs, the demand for rapid diagnostic tools that can inform clinical decisions is becoming paramount. POC testing aligns with this trend by enabling healthcare professionals to quickly assess a patient's condition and adjust treatment plans accordingly. Furthermore, global health initiatives aimed at combating infectious diseases, particularly in low-resource settings, are driving investments in POC testing technologies that can be deployed in diverse environments. Collaborative efforts between diagnostic manufacturers, healthcare organizations, and public health agencies will be essential in advancing these solutions, ensuring that the POC infectious disease testing market remains agile and responsive to emerging health challenges.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

• Lateral Flow Immunoassay
• Agglutination Test
• Flow-through test/Immunoconcentration Assay
• Molecular Diagnostics
• Others

By Disease

• HIV POC
• Clostridium Difficile POC
• HBV POC
• Pneumonia Or Streptococcus Associated Infections
• Respiratory Syncytial Virus (RSV) POC
• HPV POC
• Influenza/Flu POC
• HCV POC
• MRSA POC
• TB & Drug-resistant TB POC
• HSV POC
• COVID-19
• Others

By End Use

• Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory
• COMPANIES PROFILED
• Abbott
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers
• Becton
• Dickinson & Company
• Chembio Diagnostics Inc.
• Trinity Biotech
• Cardinal Health
• Quest Diagnostics Incorporated
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Sight Diagnostics Ltd.
• Gene POC
• Trivitron Healthcare
• OJ-Bio Ltd.
• Ortho-Clinical Diagnostics
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Disease
  • 3.7.2 Market Attractiveness Analysis By End-Use
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY DISEASE

• 5.1. Overview By Disease
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Disease
• 5.4. HIV POC Historic and Forecast Sales By Regions
• 5.5. Clostridium difficile POC Historic and Forecast Sales By Regions
• 5.6. HBV POC Historic and Forecast Sales By Regions
• 5.7. Pneumonia or Streptococcus associated infections Historic and Forecast Sales By Regions
• 5.8. Respiratory syncytial virus (RSV) POC Historic and Forecast Sales By Regions
• 5.9. HPV POC Historic and Forecast Sales By Regions
• 5.10. Influenza/Flu POC Historic and Forecast Sales By Regions
• 5.11. HCV POC Historic and Forecast Sales By Regions
• 5.12. MRSA POC Historic and Forecast Sales By Regions
• 5.13. TB and drug-resistant TB POC Historic and Forecast Sales By Regions
• 5.14. HSV (Herpes Simplex Virus) POC Historic and Forecast Sales By Regions
• 5.15. Other infectious disease POC Historic and Forecast Sales By Regions

6. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY END-USE

• 6.1. Overview By End-Use
• 6.2. Historical and Forecast Data
• 6.3. Analysis By End-Use
• 6.4. Hospitals Historic and Forecast Sales By Regions
• 6.5. Clinics Historic and Forecast Sales By Regions
• 6.6. Home Historic and Forecast Sales By Regions
• 6.7. Assisted Living Healthcare Facilities Historic and Forecast Sales By Regions
• 6.8. Laboratories Historic and Forecast Sales By Regions
• 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East Africa By Segment Sales Analysis
  • 7.7.3 Middle East Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE POINT OF CARE INFECTIOUS DISEASE TESTING COMPANIES

• 8.1. Point of Care Infectious Disease Testing Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Alere
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Thermo Fisher Scientific Inc
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. F. Hoffmann-La Roche Ltd
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Siemens Healthineers
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. BD Company
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Chembio Diagnostics Inc.
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Trinity Biotech
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Cardinal Health
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Quest Diagnostics Inc.
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Bio-Rad Labs Inc.
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. BioMéRieux SA
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. Sight Diagnostics Ltd.
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. Gene POC
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments
• 9.16. Trivitron Healthcare
  • 9.16.1 Company Overview
  • 9.16.2 Company Revenue
  • 9.16.3 Products
  • 9.16.4 Recent Developments
• 9.17. OJ-Bio Ltd.
  • 9.17.1 Company Overview
  • 9.17.2 Company Revenue
  • 9.17.3 Products
  • 9.17.4 Recent Developments
• 9.18. Ortho-Clinical Diagnostics
  • 9.18.1 Company Overview
  • 9.18.2 Company Revenue
  • 9.18.3 Products
  • 9.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies